Skip to main content

Pyxis Oncology, Inc.

PYXS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001782223

In the last 90 days, Pyxis Oncology, Inc. insiders filed 0 open-market purchases and 1 sale; 76 institutions reported holding it in 13F filings for Q2 2026, worth $101.1M in total; no superinvestor holds it.

13F holders, Q2 2022

Institutional positions in Pyxis Oncology, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
39
−5 vs. Q1 2022
Shares held
20.0M
+1.09M (+5.8%) vs. Q1 2022
Total value
$47.7M
−$28.4M (−37.3%) vs. Q1 2022
New holders
11
8 more added
Sold out
16
15 more reduced

1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting PYXS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2022: 39 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 51 institutionsQ1 2022: 45 institutionsQ2 2022: 39 institutionsQ3 2022: 38 institutionsQ4 2022: 31 institutionsQ1 2023: 47 institutionsQ2 2023: 48 institutionsQ3 2023: 54 institutionsQ4 2023: 51 institutionsQ1 2024: 71 institutionsQ2 2024: 80 institutionsQ3 2024: 92 institutionsQ4 2024: 99 institutionsQ1 2025: 89 institutionsQ2 2025: 74 institutionsQ3 2025: 73 institutionsQ4 2025: 79 institutionsQ1 2026: 78 institutionsQ2 2026: 76 institutions
Value heldQ2 2022: $47.7M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $199.9MQ1 2022: $76.1MQ2 2022: $47.7MQ3 2022: $38.3MQ4 2022: $26.5MQ1 2023: $41.5MQ2 2023: $24.6MQ3 2023: $15.4MQ4 2023: $15.8MQ1 2024: $97.7MQ2 2024: $93.1MQ3 2024: $102.3MQ4 2024: $49.2MQ1 2025: $29.6MQ2 2025: $30.2MQ3 2025: $59.7MQ4 2025: $34.7MQ1 2026: $40.5MQ2 2026: $101.1M
Institutions holding PYXS and their total value by quarter
QuarterHoldersValue
Q2 202676$101.1M
Q1 202678$40.5M
Q4 202579$34.7M
Q3 202573$59.7M
Q2 202574$30.2M
Q1 202589$29.6M
Q4 202499$49.2M
Q3 202492$102.3M
Q2 202480$93.1M
Q1 202471$97.7M
Q4 202351$15.8M
Q3 202354$15.4M
Q2 202348$24.6M
Q1 202347$41.5M
Q4 202231$26.5M
Q3 202238$38.3M
Q2 202239$47.7M
Q1 202245$76.1M
Q4 202151$199.9M
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q2 2022

Shares, value and share of portfolio for each institution holding Pyxis Oncology, Inc.; share changes are against Q1 2022.

Institutions holding PYXS in Q2 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Laurion Capital Management LP3,170,803$7.55M0.32%+1,950,971+159.9%Added
BVF Inc2,938,851$6.99M0.34%+77,000+2.7%Added
Perceptive Advisors LLC1,528,812$3.64M0.11%00.0%Unchanged
Citadel Advisors LLC1,520,936$3.62M0.00%−1,562−0.1%Reduced
Tang Capital Management LLC1,379,080$3.28M0.50%+1,379,080New
Credit Suisse AG965,465$2.30M0.00%+965,465New
Ra Capital Management, L.P.953,393$2.27M0.06%−1,328,780−58.2%Reduced
Barclays PLC947,651$2.25M0.00%−1,736−0.2%Reduced
Vanguard Group Inc849,080$2.02M0.00%+322,771+61.3%Added
Newtyn Management, LLC800,000$1.90M0.36%+800,000New
HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse)764,406$1.82M0.04%00.0%Unchanged
Tekla Capital Management LLC708,303$1.69M0.07%00.0%Unchanged
RTW Investments, LP682,220$1.62M0.04%−1,438,540−67.8%Reduced
Cormorant Asset Management, LP668,854$1.59M0.12%00.0%Unchanged
Acuta Capital Partners, LLC645,149$1.53M0.86%+445,149+222.6%Added
Citigroup Inc312,411$744.0K0.00%+79,282+34.0%Added
Logos Global Management LP220,434$525.0K0.10%−66,218−23.1%Reduced
BlackRock Inc.205,304$489.0K0.00%−315,597−60.6%Reduced
Millennium Management LLC142,815$340.0K0.00%+142,815New
Morgan Stanley136,877$325.0K0.00%+133,691+4,196.2%Added
Geode Capital Management, LLC109,847$261.0K0.00%−84,730−43.5%Reduced
Renaissance Technologies LLC75,371$179.0K0.00%+75,371New
Bridgeway Capital Management, LLC70,295$167.0K0.00%+70,295New
Two Sigma Investments, LP42,296$101.0K0.00%+42,296New
Ergoteles LLC36,415$87.0K0.00%+36,415New
State Street Corp30,989$74.0K0.00%−113,806−78.6%Reduced
Deutsche Bank AG25,000$60.0K0.00%−5,783−18.8%Reduced
Acadian Asset Management LLC23,843$57.0K0.00%+23,843New
Northern Trust Corp17,742$42.0K0.00%−70,587−79.9%Reduced
Bank of America Corp15,732$37.0K0.00%−4,546−22.4%Reduced
Susquehanna International Group, LLP14,466$34.0K0.00%+14,466New
Tudor Investment Corp Et Al13,624$32.0K0.00%00.0%Unchanged
Goldman Sachs Group Inc12,882$31.0K0.00%+12,882New
Tower Research Capital LLC (TRC)3,060$7.00K0.00%+437+16.7%Added
Legal & General Group Plc833$2.00K0.00%−142−14.6%Reduced
FMR LLC858$2.00K0.00%+729+565.1%Added
UBS Group AG367$1.00K0.00%−1,065−74.4%Reduced
New York State Common Retirement Fund108$00.00%−6,277−98.3%Reduced
Wells Fargo & Company70$00.00%−5,245−98.7%Reduced
Janus Henderson Group PLC0$00.00%−1,396,967−100.0%Sold out
HealthCor Management, L.P.0$00.00%−217,457−100.0%Sold out
OrbiMed Advisors LLC0$00.00%−143,640−100.0%Sold out
Pura Vida Investments, LLC0$00.00%−113,362−100.0%Sold out
Ghost Tree Capital, LLC0$00.00%−75,000−100.0%Sold out
Bank of New York Mellon Corp0$00.00%−32,589−100.0%Sold out
Charles Schwab Investment Management Inc0$00.00%−23,094−100.0%Sold out
Nuveen Asset Management, LLC0$00.00%−16,163−100.0%Sold out
American International Group, Inc.0$00.00%−5,278−100.0%Sold out
JPMorgan Chase & Co0$00.00%−4,986−100.0%Sold out
California State Teachers Retirement System0$00.00%−4,311−100.0%Sold out
STRS Ohio0$00.00%−2,500−100.0%Sold out
Amalgamated Bank0$00.00%−1,543−100.0%Sold out
Royal Bank of Canada0$00.00%−653−100.0%Sold out
Ameritas Investment Partners, Inc.0$00.00%−822−100.0%Sold out
Massmutual Trust Co FSB0$00.00%−133−100.0%Sold out
Amalgamated Financial Corp.––––Not filed